Skip to content

Bio-Path Holdings, Inc.: stockholders equity

Stockholders equity for Bio-Path Holdings, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.

All Bio-Path Holdings, Inc. financial histories

What this measure means

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Exact concept: us-gaap:StockholdersEquity. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2007-06-30 to 2024-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Stockholders equity in original reported units, latest-filed observation per period
Period startPeriod endValueUnitFiledSource filing
At date2024-12-31154,000USD2025-03-2710-K · 0001558370-25-003837
At date2023-12-31441,000USD2025-03-2710-K · 0001558370-25-003837
At date2022-12-3114,174,000USD2024-03-0710-K · 0001558370-24-002730
At date2021-12-3125,457,000USD2023-03-3010-K · 0001558370-23-005081
At date2020-12-3115,070,000USD2023-03-3010-K · 0001558370-23-005081
At date2019-12-3121,086,000USD2022-03-1010-K · 0001558370-22-003298
At date2018-12-311,218,000USD2021-03-0910-K · 0001104659-21-033789
At date2017-12-318,067,000USD2020-03-0510-K · 0001104659-20-029711
At date2016-12-318,240,000USD2019-03-1910-K · 0001144204-19-014855
At date2015-12-319,818,000USD2018-04-0210-K · 0001144204-18-018611
At date2014-12-3114,917,000USD2017-03-1510-K · 0001144204-17-014602
At date2013-12-314,783,000USD2017-03-1510-K · 0001144204-17-014602
At date2012-12-312,014,520USD2016-03-1510-K · 0001144204-16-088178
At date2011-12-312,914,974USD2015-03-1610-K · 0001144204-15-016335
At date2010-12-312,861,746USD2014-03-3110-K · 0001144204-14-019417
At date2009-12-313,416,763USD2014-03-3110-K · 0001144204-14-019417
At date2009-09-303,107,344USD2014-03-3110-K · 0001144204-14-019417
At date2009-06-303,371,750USD2014-03-3110-K · 0001144204-14-019417
At date2009-03-313,607,984USD2014-03-3110-K · 0001144204-14-019417
At date2008-12-314,060,020USD2014-03-3110-K · 0001144204-14-019417
At date2008-09-304,538,099USD2014-03-3110-K · 0001144204-14-019417
At date2008-06-304,759,264USD2014-03-3110-K · 0001144204-14-019417
At date2008-03-315,003,497USD2014-03-3110-K · 0001144204-14-019417
At date2007-12-313,743,235USD2014-03-3110-K · 0001144204-14-019417
At date2007-09-301,592,775USD2014-03-3110-K · 0001144204-14-019417
At date2007-06-30-76,477USD2014-03-3110-K · 0001144204-14-019417

Related financial histories

Inspect the source

Entity
Bio-Path Holdings, Inc. / CIK 0001133818
Captured
2026-09-20T07:41:23.212Z
SEC response SHA-256
ba1a5b94a703d7df40927e88576df9dbcb07b38680ce9a942065f8bd6fea9eee

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001133818.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))